The Metabolomic Rationale for Treating Perimenopausal Syndrome as Kidney Deficiency

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Rats</td><td class="align_center">E2 (pg/mL)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">6 months old</td><td class="align_center">6.9 ± 1.1</td></tr><tr><td class="align_left">Perimenopausal</td><td class="align_center">4.9 ± 0.6</td></tr><tr><td class="align_left">Yougui-treated</td><td class="align_center">3.8 ± 0.5</td></tr><tr><td class="align_left">Zuogui-treated</td><td class="align_center">4.3 ± 0.6</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Evidence-Based Complementary and Alternative Medicine

tab3

Table 3

Table 3: The Metabolomic Rationale for Treating Perimenopausal Syndrome as Kidney Deficiency 